| NCLH |
Report |
Net Yield CC Growth (Q2 2026) |
IN-LINE |
pred ~-3.2% vs. cons -3.46% |
MEDIUM |
| NCLH |
Report |
Adj. EBITDA (Q2 2026) |
BEAT |
pred ~$645M vs. cons $636M |
MEDIUM |
| NCLH |
Report |
Adj. EPS (Q2 2026) |
BEAT |
pred ~$0.41 vs. cons $0.39 |
MEDIUM |
| NCLH |
Guide |
Net Yield CC Growth (FY 2026) |
UNCHANGED |
guide ~-4% mid vs. cons -4.12% |
MEDIUM |
| NCLH |
Guide |
Net Yield CC Growth (Q3 2026) |
LOWER |
guide ~-7% to -8% vs. cons UNVERIFIED |
LOW |
| NCLH |
Guide |
Adj. EPS (FY 2026) |
UNCHANGED |
guide ~$1.62 mid vs. cons $1.66 |
MEDIUM |
| NCLH |
Guide |
Adj. EBITDA (FY 2026) |
UNCHANGED |
guide ~$2.56B mid vs. cons $2.57B |
MEDIUM |
| NCLH |
Return |
Day-1 residual (stock − beta × S&P 500) |
-4.0% |
— |
MEDIUM |
| NCLH |
Return |
5-day cumulative residual |
-6.0% (STABILIZE) |
STABILIZE — short cover bid limits Day-1 damage; sell-side H2 math pulls estimates lower over 5 days |
MEDIUM |